18 May 2013
Keywords: merck, gets, approval, new, carbapenem, antibiotic, co
Article | 30 November 2001
Merck & Co has been granted approval by the US Food and DrugAdministration for Invanz (ertapenem sodium), a new once-daily
Enjoying this article? To continue reading you need to login or subscribe.
Subscriptions are £60 per month, pay as you go.
Find out more details.
30 November 2001
29 November 2001
17 May 2013
© 2013 thepharmaletter.com